C12N 5/0696
Artificially induced pluripotent stem cells
Official title: {Artificially induced pluripotent stem cells, e.g. iPS}
C12N5/0696 (Artificially induced pluripotent stem cells) appears on 984 US grants and 2,169 published applications in this corpus.
Search patents in C12N- Granted patents
- 984
- Published applications
- 2,169
- Assignees
- 780
- Inventors
- 3,417
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 3 |
| 2003 | 0 | 3 |
| 2004 | 0 | 9 |
| 2005 | 0 | 4 |
| 2006 | 0 | 6 |
| 2007 | 2 | 4 |
| 2008 | 2 | 6 |
| 2009 | 2 | 15 |
| 2010 | 3 | 49 |
| 2011 | 7 | 71 |
| 2012 | 18 | 87 |
| 2013 | 19 | 94 |
| 2014 | 39 | 101 |
| 2015 | 59 | 99 |
| 2016 | 62 | 111 |
| 2017 | 58 | 130 |
| 2018 | 75 | 124 |
| 2019 | 81 | 195 |
| 2020 | 79 | 147 |
| 2021 | 66 | 165 |
| 2022 | 81 | 183 |
| 2023 | 81 | 146 |
| 2024 | 103 | 159 |
| 2025 | 94 | 158 |
| 2026 | 53 | 100 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Composition for enhancing reprogramming efficiency from somatic cell to induced pluripotent stem cell, comprising mTOR activator, and method for enhancing reprogramming efficiency by using same6 Oct 2026US 12,753,394 B2Korea University Research and Business Foundation
- Gene-therapy vectors for treating cardiomyopathy29 Sep 2026US 12,747,453 B2
- Gene-therapy vectors for treating cardiomyopathy22 Sep 2026US 12,742,181 B2
- Methods for directed differentiation of pluripotent stem cells to HLA homozygous immune cells25 Aug 2026US 12,716,058 B2FUJIFILM Cellular Dynamics, Inc.
- Diagnostic and drug screening for molecular signatures of early onset sporadic parkinson's disease18 Aug 2026US 12,708,611 B2Cedars-Sinai Medical Center
- Ribosomal Remodeling in Diabetes1 Oct 2026US 2026/0295074 A1Joslin Diabetes Center, Inc.
- Method of producing a mesodermal-lineage primitive streak cell1 Oct 2026US 2026/0297533 A1Kyoto University
- Oct3/4 protein variants, and method for producing induced pluripotent stem cells1 Oct 2026US 2026/0297535 A1Riken
- System, apparatus and method for spheroidal pluripotent stem cell generation using cold-triggered detachment1 Oct 2026US 2026/0297536 A1HOHCells, LLC
- Reprogramming methods and cell culture platforms1 Oct 2026US 2026/0297537 A1Fate Therapeutics, Inc.
Most cited
By later US patents
- RNA containing modified nucleosides and methods of use thereof353US 8,278,036 B2The Trustees of the University of Pennsylvania · 2012
- RNA containing modified nucleosides and methods of use thereof230US 8,691,966 B2The Trustees of the University of Pennsylvania · 2014
- RNA containing modified nucleosides and methods of use thereof222US 8,748,089 B2The Trustees of the University of Pennsylvania · 2014
- RNA containing modified nucleosides and methods of use thereof198US 8,835,108 B2The Trustees of the University of Pennsylvania · 2014
- Kits comprising linear DNAs for sustained polypeptide expression using synthetic, modified RNAs156US 8,883,506 B2Children's Medical Center Corporation · 2014